Mirtazapine Tablet, Film Coated
Product Images NDC 71335-3038

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 71335-3038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713353038)

Label (Lbl713353038)
Label for Mirtazapine Tablets USP 7.5 mg, 30 tablets per bottle. The product is relabeled by Bryant Ranch Prepack, Inc. and manufactured by Aurobindo Pharma Limited. The label includes the NDC 71335-3038-1, storage instructions, dispensing information, and QR codes for additional prescribing and medication guide information.*
FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

Mirtazpine Structure (Mirtazapine Str)
Chemical structure of the active ingredient Mirtazapine depicted as a molecular diagram showing interconnected rings and a methyl group attached to the nitrogen atom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.